BIOMAT Database Logo BIOMAT Database Logo

Comparison of skin allograft rejection and cytotoxic antibody production in two lines of mice genetically selected for "high" and "low" antibody synthesis. 1972

M Liacopoulos-Briot, and Y Bouthillier, and D Mouton, and F Lambert, and C Decreusefond, and C Stiffel, and G Biozzi

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007518 Isoantibodies Antibodies from an individual that react with ISOANTIGENS of another individual of the same species. Alloantibodies
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003601 Cytotoxicity Tests, Immunologic The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. AHG-CDC Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Tests,Microcytotoxicity Tests,Anti Human Globulin Complement Dependent Cytotoxicity Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunologic,Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent,Cytotoxicity Tests, Immunological,Immunologic Cytotoxicity Test,Immunologic Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin-Augmented,Lymphocytotoxicity Tests, Antiglobulin-Augmented,Microcytotoxicity Test,AHG CDC Tests,AHG-CDC Test,Anti Human Globulin Complement Dependent Cytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunological,Cytotoxicity Tests, Anti Human Globulin Complement Dependent,Immunological Cytotoxicity Test,Immunological Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin Augmented,Lymphocytotoxicity Tests, Antiglobulin Augmented
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections

Related Publications

M Liacopoulos-Briot, and Y Bouthillier, and D Mouton, and F Lambert, and C Decreusefond, and C Stiffel, and G Biozzi
Resistance to listeriosis in two lines of mice genetically selected for high and low antibody production.
December 1985, Immunology,
M Liacopoulos-Briot, and Y Bouthillier, and D Mouton, and F Lambert, and C Decreusefond, and C Stiffel, and G Biozzi
Cytodynamics of the immune response in two lines of mice genetically selected for "high" and "low" antibody synthesis.
May 1972, The Journal of experimental medicine,
M Liacopoulos-Briot, and Y Bouthillier, and D Mouton, and F Lambert, and C Decreusefond, and C Stiffel, and G Biozzi
Serum concentrations and allotypes of immunoglobulins in two lines of mice genetically selected for "high" or "low" antibody synthesis.
October 1970, The Journal of experimental medicine,
M Liacopoulos-Briot, and Y Bouthillier, and D Mouton, and F Lambert, and C Decreusefond, and C Stiffel, and G Biozzi
Trichinella infestation in mice genetically selected for high and low antibody production.
August 1975, Immunology,
M Liacopoulos-Briot, and Y Bouthillier, and D Mouton, and F Lambert, and C Decreusefond, and C Stiffel, and G Biozzi
Differential effects of ethanol in mouse lines genetically selected for high and low antibody production.
September 1993, Brain, behavior, and immunity,
M Liacopoulos-Briot, and Y Bouthillier, and D Mouton, and F Lambert, and C Decreusefond, and C Stiffel, and G Biozzi
Gut dysbiosis in mice genetically selected for low antibody production.
January 2017, Gut pathogens,
M Liacopoulos-Briot, and Y Bouthillier, and D Mouton, and F Lambert, and C Decreusefond, and C Stiffel, and G Biozzi
H-2 typing of mice genetically selected for high or low antibody production.
January 1990, Immunogenetics,
M Liacopoulos-Briot, and Y Bouthillier, and D Mouton, and F Lambert, and C Decreusefond, and C Stiffel, and G Biozzi
[Intensity of the delayed hypersensitivity reaction in mice from lines genetically selected for "high" and "low" antibody production (author's transl)].
June 1974, Annales d'immunologie,
M Liacopoulos-Briot, and Y Bouthillier, and D Mouton, and F Lambert, and C Decreusefond, and C Stiffel, and G Biozzi
A comparison of the immune response to DNP in mice genetically selected for high or low antibody synthesis.
August 1972, Immunochemistry,
M Liacopoulos-Briot, and Y Bouthillier, and D Mouton, and F Lambert, and C Decreusefond, and C Stiffel, and G Biozzi
Macrophage activity in rabies virus infection of genetically selected high and low antibody responder lines of mice.
January 1990, Research in virology,
Copied contents to your clipboard!